Navigation Links
APIC 2009 'Targeting Zero' Initiative Offers Practical Tools, Evidence-Based Elimination Strategies to Prevent the Deadliest Healthcare-Associated Infections
Date:1/22/2009

WASHINGTON, Jan. 22 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) has expanded its successful Targeting Zero initiative for 2009 to offer comprehensive education and guidance to prevent the most common and fatal healthcare-associated infections (HAIs).

Targeting Zero features Webinars, conferences and practical tools such as HAI elimination guides. APIC's evidence-based elimination guides translate CDC recommendations into straightforward infection prevention strategies for healthcare workers.

In 2009, APIC will publish a new elimination guide for ventilator-associated pneumonia (VAP), the leading cause of death from HAIs. VAP is a type of pneumonia occurring in people being assisted by mechanical ventilators. In addition to VAP, APIC will also publish elimination guides for catheter-associated urinary tract infections (UTIs), catheter-associated blood stream infections, MRSA in long-term care settings and Acinetobacter baumannii, an antibiotic-resistant bacterium causing infections in wounded military personnel.

"APIC will continue to provide direction and guidance for healthcare workers through clearly outlined implementation strategies for reduction of HAIs," said APIC CEO Kathy Warye. "Our expanded offering has been developed in response to infection preventionists and healthcare leaders who are under increased pressure to improve outcomes and preserve healthcare dollars. As we have since 1973, APIC will help institutions bring the science of HAI reduction to the bedside."

In addition to the new elimination guides, APIC will conduct a 2009 follow-up survey to its ground-breaking MRSA Prevalence Study, first released in 2007. The purpose of the survey will be to gain a better understanding of changes in MRSA prevalence as well as current interventions and their impact.

Also slated for 2009 is a conference focusing on regulatory issues in infection prevention and a series of educational offerings on safe injection practices in ambulatory surgery centers. Additionally, APIC will launch a program to share success stories on performance improvement.

Targeting Zero was initiated in 2008 with educational programs aimed at preventing MRSA, Clostridium difficile infection and the three infections considered preventable by the Centers for Medicare & Medicaid Services (CMS): catheter-associated urinary tract infections (UTIs), catheter-associated blood stream infections, and mediastinitis (a deep infection following coronary artery bypass surgery). A two-day conference for healthcare executives on the new CMS regulations that reduce payment for HAIs was held in September.

As part of the 2008 Targeting Zero initiative APIC conducted a National Prevalence Study of C. difficile in U.S. Healthcare Facilities, the first study to calculate the true magnitude of this infection in the nation's hospitals. The study indicated that 13 out of every 1,000 inpatients were either infected or colonized with C. difficile, a rate 6.5 to 20 times greater than previous incidence estimates. C. difficile is a bacterium that causes diarrhea and more serious intestinal conditions such as colitis.

"New pay-for-performance mandates from CMS and private insurers are driving increased interest in infection prevention," said Warye. "But the most important reason to eliminate HAIs is to save lives and reduce suffering. While not all infections are preventable, working toward zero should be the goal. APIC urges all healthcare institutions to pursue zero HAIs and address the resources, systems and cultural changes that will support this effort."

For more information about APIC Targeting Zero educational programs, please visit: http://www.apic.org/AM/Template.cfm?Section=Targeting_Zero

APIC Targeting Zero 2009

APIC will publish new elimination guides for:

  • VAP (ventilator-associated pneumonia)
  • Catheter-associated urinary tract infections (UTIs)
  • Catheter-associated blood stream infections
  • MRSA in long-term care settings
  • Acinetobacter baumannii

HAIs are a critical public health issue, affecting nearly 2 million Americans annually, with 99,000 deaths and an estimated $20 billion in healthcare costs, according to the CDC.

The CDC estimates the most common HAIs are urinary tract infections (32 percent), surgical site infections (22 percent), pneumonias (15 percent), and blood stream infections (14 percent).

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The association's 12,000 members direct infection prevention programs that save lives and improve the bottom line for hospitals and other healthcare facilities around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy and credentialing. Visit APIC online at www.apic.org


'/>"/>
SOURCE Association for Professionals in Infection Control and Epidemiology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Targeting Cancers Own Stem Cells to Fight Recurrence
2. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
3. Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic
4. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
5. EGFR-targeting antibody licensed to Abbott
6. Tackling a hard-to-treat childhood cancer by targeting epigenetic changes
7. Tackling Hard-to-treat Childhood Cancer by Targeting Epigenetic Changes
8. NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African-American Voters
9. Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms
10. USHEALTH Group Launches Marketing Program for Two Health Insurance Plans Targeting Latino Residents in Florida
11. L.A. City Attorney Rocky Delgadillo, Patient Activists to Unveil New Television Ad Targeting Health Insurers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Dudnyk has announced the launch of its new brand identity, ... potential of specialty and orphan brands can only be achieved when the needs and ... Effect is at the heart of a true partnership between our agency and our ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , ... , an active lifestyle company that provides Human Performance Training and education to ... offers, first responders, military officers and others in service through the development and ...
(Date:4/21/2017)... UK (PRWEB) , ... April 21, 2017 , ... ... for Enterprise in the category of International Trade, the UK’s most prestigious award ... international trade, which represents 95% of total revenues and has grown by a ...
(Date:4/21/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, wrote an ... crisis with solution to peace plan. Yisrayl says war has never brought peace and he ... the Creator Himself. , Yisrayl says war drums are beating all over the media ...
(Date:4/21/2017)... ... 21, 2017 , ... Indiana Fiber Network, LLC (IFN), the ... to Tele-Media Solutions. IFN is delivering Multi-Gigabit data rates as an upstream ... protect transport with 3GB Dual Access Internet access now available in their service ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology: